Scientists around the world agree that we are facing a shortage of effective antibiotics. Innovation is needed now. This is a problem that affects all Americans — and people with cystic fibrosis in particular.
Scientists around the world agree that global innovation is needed to address the shortage of effective antibiotics. Our Infection Research Initiative supports much-needed research and development, but new policies are needed to promote a sustainable, robust antibiotics pipeline and a marketplace that rewards innovation.